301 related articles for article (PubMed ID: 9032177)
41. Eosinophil soluble protein levels, eosinophil peroxidase and eosinophil cationic protein in asthmatic patients.
Parra A; Sanz ML; Vila L; Prieto I; Diéguez I; Oehling AK
J Investig Allergol Clin Immunol; 1999; 9(1):27-34. PubMed ID: 10212854
[TBL] [Abstract][Full Text] [Related]
42. The relationship between airways inflammation and asthma severity.
Louis R; Lau LC; Bron AO; Roldaan AC; Radermecker M; Djukanović R
Am J Respir Crit Care Med; 2000 Jan; 161(1):9-16. PubMed ID: 10619791
[TBL] [Abstract][Full Text] [Related]
43. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
[TBL] [Abstract][Full Text] [Related]
44. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
[TBL] [Abstract][Full Text] [Related]
45. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
[TBL] [Abstract][Full Text] [Related]
46. Induced sputum to assess airway inflammation: a study of reproducibility.
Spanevello A; Migliori GB; Sharara A; Ballardini L; Bridge P; Pisati P; Neri M; Ind PW
Clin Exp Allergy; 1997 Oct; 27(10):1138-44. PubMed ID: 9383253
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).
Grootendorst DC; Gauw SA; Benschop N; Sterk PJ; Hiemstra PS; Rabe KF
Pulm Pharmacol Ther; 2003; 16(6):341-7. PubMed ID: 14580925
[TBL] [Abstract][Full Text] [Related]
48. Changes in inflammatory markers following treatment of acute exacerbations of obstructive pulmonary disease.
Dahlén I; Janson C; Björnsson E; Stålenheim G; Peterson CG; Venge P
Respir Med; 2001 Nov; 95(11):891-7. PubMed ID: 11716203
[TBL] [Abstract][Full Text] [Related]
49. Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT.
Ekberg-Jansson A; Andersson B; Bake B; Boijsen M; Enanden I; Rosengren A; Skoogh BE; Tylén U; Venge P; Löfdahl CG
Respir Med; 2001 May; 95(5):363-73. PubMed ID: 11392577
[TBL] [Abstract][Full Text] [Related]
50. Does eosinophil cationic protein in sputum and blood reflect bronchial inflammation and obstruction in allergic asthmatics?
Grebski E; Wu J; Wüthrich B; Medici TC
J Investig Allergol Clin Immunol; 1999; 9(2):82-8. PubMed ID: 10353094
[TBL] [Abstract][Full Text] [Related]
51. [What role does eosinophil cationic protein have in the evaluation of asthma severity?].
Nieto A
Allergol Immunopathol (Madr); 2000; 28(3):119-24. PubMed ID: 10867382
[TBL] [Abstract][Full Text] [Related]
52. Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma.
Rao R; Frederick JM; Enander I; Gregson RK; Warner JA; Warner JO
Clin Exp Allergy; 1996 Jul; 26(7):789-93. PubMed ID: 8842552
[TBL] [Abstract][Full Text] [Related]
53. Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects.
Metso T; Venge P; Haahtela T; Peterson CG; Sevéus L
Thorax; 2002 May; 57(5):449-51. PubMed ID: 11978925
[TBL] [Abstract][Full Text] [Related]
54. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function.
Hällgren R; Bjermer L; Lundgren R; Venge P
Am Rev Respir Dis; 1989 Feb; 139(2):373-7. PubMed ID: 2536526
[TBL] [Abstract][Full Text] [Related]
55. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
Pedersen B; Dahl R; Karlström R; Peterson CG; Venge P
Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596
[TBL] [Abstract][Full Text] [Related]
56. Correlation between IgA antibody and eosinophil cationic protein levels in induced sputum from asthmatic patients.
Nahm DH; Park HS
Clin Exp Allergy; 1997 Jun; 27(6):676-81. PubMed ID: 9208189
[TBL] [Abstract][Full Text] [Related]
57. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
Iwamoto H; Gao J; Koskela J; Kinnula V; Kobayashi H; Laitinen T; Mazur W
Eur Respir J; 2014 Feb; 43(2):421-9. PubMed ID: 23794464
[TBL] [Abstract][Full Text] [Related]
58. Increased levels of nitric oxide derivatives in induced sputum in patients with asthma.
Kanazawa H; Shoji S; Yamada M; Fujii T; Kawaguchi T; Kudoh S; Hirata K; Yoshikawa J
J Allergy Clin Immunol; 1997 May; 99(5):624-9. PubMed ID: 9155829
[TBL] [Abstract][Full Text] [Related]
59. Eosinophil cationic protein and interleukin-8 levels in bronchial lavage fluid from children with asthma and infantile wheeze.
Marguet C; Dean TP; Basuyau JP; Warner JO
Pediatr Allergy Immunol; 2001 Feb; 12(1):27-33. PubMed ID: 11251862
[TBL] [Abstract][Full Text] [Related]
60. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease.
Peterson CG; Eklund E; Taha Y; Raab Y; Carlson M
Am J Gastroenterol; 2002 Jul; 97(7):1755-62. PubMed ID: 12135031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
